New Perspective in Atrial Fibrillation |
Autore | Guenancia Charles |
Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 |
Descrizione fisica | 1 electronic resource (224 p.) |
Soggetto topico | Medicine |
Soggetto non controllato |
postoperative atrial fibrillation
biomarkers coronary artery bypass grafting miRNA circRNA mtDNA SNPs atrial fibrillation acute myocardial infarction heart rate variability autonomic nervous system bleeding risk age left atrial appendage closure coronary artery disease prognosis anticoagulation antiplatelet therapy hypertension elderly prevention ganglionated plexi ablation dementia early-onset ischemic stroke risk factor new oral anticoagulants mitochondria cardiac remodeling pharmacotherapy electroporation pulsed field ablation cardiac heart arrhythmia NOAC VKA statin outcome mortality paroxysmal atrial fibrillation catheter ablation epicardial adipose tissue persistent atrial fibrillation posterior wall hybrid ablation convergent ablation atrial tachycardia mechanism spatiotemporal dispersion left atrial appendage occlusion BNP atrial remodeling atrial cardiopathy cardiac ablation irreversible electroporation |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910557507203321 |
Guenancia Charles
![]() |
||
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Risk Prediction and New Prophylaxis Strategies for Thromboembolism in Cancer |
Autore | Ferroni Patrizia |
Pubbl/distr/stampa | Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
Descrizione fisica | 1 electronic resource (202 p.) |
Soggetto topico |
Medicine
Oncology |
Soggetto non controllato |
multiple myeloma
venous thromboembolism risk assessment models thromboprophylaxis direct oral anticoagulants cancer-associated venous thromboembolism thrombosis pulmonary embolism neoplasms anticoagulants coumarins low molecular weight heparins cancer endogenous heparin heparanase heparan sulfate hospice palliative care units low molecular weight heparin deep vein thrombosis cancer associated thrombosis VTE malignancy direct oral anticoagulant pancreatic cancer low-molecular weight heparin survival coagulation activation locally advanced breast cancer prognostic model pCR treatment prophylaxis DOAC simultaneous care integrated care lymphoma Non-Hodgkin lymphoma Hodgkin lymphoma risk factors molecular subtype arterial thrombosis ALK ROS1 KRAS chemotherapy low-molecular-weight heparin (LMWH) VKA UFH DOACs |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910585935803321 |
Ferroni Patrizia
![]() |
||
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|